ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Official Says Public Health Issue As Important As Data In Mammography

April 2, 1993

Cigarette use declining among high school students, report finds.

June 25, 2004

Raub Briefs Councils On Women’s Health, Cost Containment

October 12, 1990

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005

In Brief: Illinois Comprehensive Center Core Grant Approved, Probably Will Be Funded in FY 79

September 29, 1978

In Brief: GM Cancer Research Foundation Awards Three Prizes to Five Cancer Researchers

May 5, 2000